$PZG
Paramount Gold Nevada Corp

2018 Q3 Form 10-Q Financial Statement

#000156459018028016 Filed on November 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q3
Revenue $104.5K $236.8K $85.55K
YoY Change 22.18% -8188.25% 1512.29%
Cost Of Revenue $160.0K $120.0K $160.0K
YoY Change 0.0% -14.29% 6.67%
Gross Profit -$60.00K $120.0K -$80.00K
YoY Change -25.0% -185.71% -46.67%
Gross Profit Margin -57.4% 50.67% -93.51%
Selling, General & Admin $440.0K $340.0K $300.0K
YoY Change 46.67% -26.09% -40.0%
% of Gross Profit 283.33%
Research & Development $470.0K $1.220M $650.0K
YoY Change -27.69% -48.74% 20.37%
% of Gross Profit 1016.67%
Depreciation & Amortization $0.00 $0.00 $938.00
YoY Change -100.0% -14.88%
% of Gross Profit 0.0%
Operating Expenses $990.0K $1.630M $1.170M
YoY Change -15.39% -43.99% -7.89%
Operating Profit -$1.050M -$1.513M -$1.085M
YoY Change -3.19% -50.42% -14.26%
Interest Expense $0.00 $10.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$1.059M -$1.510M -$1.083M
YoY Change -2.2% -50.33% -14.2%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.059M -$1.508M -$1.083M
YoY Change -2.2% -50.46% -155.42%
Net Earnings / Revenue -1013.09% -636.67% -1265.63%
Basic Earnings Per Share -$0.04 -$0.07 -$0.06
Diluted Earnings Per Share -$0.04 -$0.07 -$0.06
COMMON SHARES
Basic Shares Outstanding 25.19M 17.78M
Diluted Shares Outstanding 25.19M 17.78M

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.570M $300.0K $90.00K
YoY Change 1644.44% -84.29% -97.58%
Cash & Equivalents $1.566M $297.4K $90.00K
Short-Term Investments
Other Short-Term Assets $550.0K $16.29K $198.0K
YoY Change 177.79% -92.24% -64.0%
Inventory
Prepaid Expenses
Receivables $0.00 $16.29K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.120M $557.8K $929.1K
YoY Change 128.17% -73.94% -78.29%
LONG-TERM ASSETS
Property, Plant & Equipment $48.87M $8.927K $11.72K
YoY Change 416843.95% -29.48% -99.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.680M $1.770M $2.090M
YoY Change -19.62% -15.31% -11.06%
Total Long-Term Assets $50.55M $50.64M $48.56M
YoY Change 4.1% 4.28% -0.55%
TOTAL ASSETS
Total Short-Term Assets $2.120M $557.8K $929.1K
Total Long-Term Assets $50.55M $50.64M $48.56M
Total Assets $52.67M $51.20M $49.49M
YoY Change 6.43% 0.98% -6.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $540.0K $930.0K $700.0K
YoY Change -22.86% 6.9% 29.63%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $640.0K $1.030M $920.0K
YoY Change -30.43% -5.55% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $910.0K $970.0K $1.080M
YoY Change -15.74% -6.73% 2.86%
Total Long-Term Liabilities $910.0K $970.0K $1.080M
YoY Change -15.74% -6.73% 2.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $640.0K $1.030M $920.0K
Total Long-Term Liabilities $910.0K $970.0K $1.080M
Total Liabilities $1.560M $2.001M $2.000M
YoY Change -22.0% -6.08% 1.01%
SHAREHOLDERS EQUITY
Retained Earnings -$41.73M
YoY Change
Common Stock $90.93M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.11M $49.20M $47.49M
YoY Change
Total Liabilities & Shareholders Equity $52.67M $51.20M $49.49M
YoY Change 6.42% 0.98% -6.81%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q3
OPERATING ACTIVITIES
Net Income -$1.059M -$1.508M -$1.083M
YoY Change -2.2% -50.46% -155.42%
Depreciation, Depletion And Amortization $0.00 $0.00 $938.00
YoY Change -100.0% -14.88%
Cash From Operating Activities -$1.643M -$920.0K -$1.819M
YoY Change -9.7% -64.06% 56.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.911M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.911M -190.0K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.643M -920.0K -1.819M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 2.911M -190.0K 0.000
Net Change In Cash 1.269M -1.110M -1.819M
YoY Change -169.73% -56.64% -15.78%
FREE CASH FLOW
Cash From Operating Activities -$1.643M -$920.0K -$1.819M
Capital Expenditures $0.00
Free Cash Flow -$920.0K
YoY Change -64.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 pzg Land Holding Costs
LandHoldingCosts
161112
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
18075
CY2018Q3 dei Document Type
DocumentType
10-Q
CY2018Q3 dei Amendment Flag
AmendmentFlag
false
CY2018Q3 dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
CY2018Q3 dei Trading Symbol
TradingSymbol
PZG
CY2018Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018Q3 pzg Prepaid And Deposit Assets Current
PrepaidAndDepositAssetsCurrent
554677
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16292
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1565936
CY2018Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2018Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1084587
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3818
CY2017Q3 pzg Interest And Service Charges
InterestAndServiceCharges
1950
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1082719
CY2018 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
6626898
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6068154
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61793
CY2018Q3 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
2911286
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-1058893
CY2017Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-169498
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
142921
CY2017Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20953
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113602
CY2017Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
27938
CY2017Q3 us-gaap Depreciation
Depreciation
938
CY2017Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
37684
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1170135
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-1082719
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61793
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5953
CY2018Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
6508
CY2017Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
3816
CY2017Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
80135
CY2017Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
197988
CY2017Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
329612
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1642739
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1819193
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2911286
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2911286
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
277738
CY2018Q3 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated interim financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made by management in the condensed consolidated interim financial statements include the adequacy of the Company&#8217;s asset retirement obligations, valuation of deferred tax assets and liabilities, and valuation of mineral properties.</p></div>
CY2018Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents and amounts receivable.&nbsp;&nbsp;The Company maintains cash and cash equivalents in accounts which may, at times, exceed federally insured limits.&nbsp;&nbsp;At September 30, 2018, the Company had $1.27 million of balances in excess of federally insured limits.&nbsp;&nbsp;We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss.</p></div>
CY2018Q3 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
1270000
CY2018Q3 pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss
CY2018Q3 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2017Q3 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2400000
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.25
CY2018Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2018Q3 pzg Sale Of Equity Units Description Of Transaction
SaleOfEquityUnitsDescriptionOfTransaction
Each unit consists of one share of common stock and one warrant to purchase one-half of a share of common stock.
CY2018Q3 pzg Class Of Warrant Or Right Description
ClassOfWarrantOrRightDescription
Each warrant will have a two-year term and will be exercisable at the following exercise prices: in the first year at $1.30 per share and in the second year at $1.50 per share.
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23074954
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23074954
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
557329
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
557329
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M29D
CY2018Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1072551
CY2017Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1261034
CY2018 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
150736
CY2018Q3 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
99001
CY2018 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
339219
CY2018Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1014926
CY2018Q3 us-gaap Insurance Recoveries
InsuranceRecoveries
99001
CY2017Q3 us-gaap Insurance Recoveries
InsuranceRecoveries
80145
CY2018Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5520
CY2017Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5403
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
7614
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10364
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
10575
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
15635

Files In Submission

Name View Source Status
0001564590-18-028016-index-headers.html Edgar Link pending
0001564590-18-028016-index.html Edgar Link pending
0001564590-18-028016.txt Edgar Link pending
0001564590-18-028016-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gltftyzs4xu2000001.jpg Edgar Link pending
pzg-10q_20180930.htm Edgar Link pending
pzg-20180930.xml Edgar Link completed
pzg-20180930.xsd Edgar Link pending
pzg-20180930_cal.xml Edgar Link unprocessable
pzg-20180930_def.xml Edgar Link unprocessable
pzg-20180930_lab.xml Edgar Link unprocessable
pzg-20180930_pre.xml Edgar Link unprocessable
pzg-ex311_7.htm Edgar Link pending
pzg-ex312_8.htm Edgar Link pending
pzg-ex321_6.htm Edgar Link pending
pzg-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending